Minerva Neurosciences Inc. sell Global_Player
Start price
29.08.22
/
50%
€14.42
Target price
29.08.23
-
Performance (%)
-59.22%
End price
19.05.23
€5.88
Summary
This prediction ended on 19.05.23 with a price of €5.88. Global_Player correctly predicted massive losses of -59.22% for Minerva Neurosciences Inc.. Global_Player has 50% into this predictionMinerva Neurosciences (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients suffering from neuropsychiatric disorders. With a primary emphasis on central nervous system diseases such as schizophrenia, major depressive disorder, insomnia, and Parkinson's, Minerva Neurosciences is committed to addressing unmet medical needs and advancing the understanding of the underlying biology of these conditions. Utilizing a strong research and development platform, the company aims to create a diversified portfolio of novel therapies that have the potential to significantly improve patients' quality of life and help them lead more fulfilling lives.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Minerva Neurosciences Inc. | 1.709% | 1.709% | -14.388% |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to Global_Player what are the pros and cons of Minerva Neurosciences Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Global_Player for this prediction
In the thread Minerva Neurosciences Inc. diskutieren
Sell Minerva Neurosciences Inc.